Mercado global da síndrome de Shwachman-Diamond – Tendências do setor e previsão para 2028

Análise de mercado e insights: mercado global da síndrome de Shwachman-Diamond

Espera-se que o mercado de síndrome de shwachman-diamante ganhe crescimento de mercado no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa que o mercado está a crescer a um CAGR de 5,10% no período de previsão de investigação acima referido. A investigação e o desenvolvimento contínuos relacionados com o mercado podem aumentar o crescimento do mercado da síndrome do diamante de shwachman.

Por exemplo,

• Foi descoberto um novo chip de órgão que vai ajudar a conhecer o comportamento da medula óssea no doente com síndrome de Shwachman-Diamante.  

A síndrome de Shwachman-diamante é uma doença hereditária e genética cujos órgãos-alvo são o pâncreas , a medula óssea e os ossos. Caracteriza-se pela má absorção ou absorção insuficiente de gorduras e outros nutrientes importantes. A razão por detrás da absorção inadequada são as anomalias na medula óssea e no pâncreas, que resultam num menor número de células sanguíneas circulantes. Pode ainda provocar anomalias no fígado e formação de ossos nos braços ou nas pernas, afetando a caixa torácica. Os doentes são também afetados pela neutropenia , que é a diminuição do número de leucócitos. A doença afeta homens e mulheres numa proporção de aproximadamente 1,7 para 1.

A população-alvo da doença são sobretudo bebés e crianças. Devido ao aumento da população de bebés e crianças, juntamente com o historial familiar da doença são os fatores que podem impulsionar o crescimento do mercado da síndrome do diamante de shwachman. A síndrome de Shwachman-diamante é uma doença muito rara, pelo que existem profissionais menos qualificados e com conhecimento sobre a condição que atua como fator restritivo para o crescimento do mercado da síndrome de shwachman-diamante. Além disso, a menor disponibilidade de tratamentos avançados também pode dificultar o crescimento do mercado da síndrome do diamante de shwachman.  

This shwachman-diamond syndrome market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the shwachman-diamond syndrome market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Shwachman-Diamond Syndrome Market Scope and Market Size

The shwachman-diamond syndrome market is segmented on the basis of diagnosis, treatment, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of diagnosis, the shwachman-diamond syndrome market is segmented into hematology, genetic testing, imaging test and others. Hematology test is further segmented to complete blood count, bone marrow examination, hemoglobin F evaluation and stool examination. Imaging test is further segmented to computed tomography (CT) scanning, abdominal ultrasound and magnetic resonance imaging (MRI). Others are further segmented to prothrombin time test, vitamin A, D, E and K levels and skeletal survey.
• On the basis of treatment, the shwachman-diamond syndrome market is segmented into pancreatic enzyme supplements, vitamins supplements, granulocyte-colony stimulating factor, hematopoietic stem cell transplantation and red cell or platelet transfusion. Vitamins supplements are further segmented to fat-soluble vitamins. Fat-soluble vitamins are further sub-segmented to vitamin A, vitamin D, vitamin E and vitamin K.
• On the basis of end user, the shwachman-diamond syndrome market is segmented to hospitals, speciality clinics and others.
• On the basis of distribution channel, the shwachman-diamond syndrome market is segmented into hospital pharmacy, retail pharmacy and others.  

Global Shwachman-Diamond Syndrome Market Country Level Analysis

Global shwachman-diamond syndrome Market is analysed and market size information is provided by country, diagnosis, treatment, end user, and distribution channel as referenced above.

The countries covered in the shwachman-diamond syndrome market report are the U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

On geographical estimation, North America has the largest market share as the presence of key manufacturers of the product is high and increasing research and development activities, healthcare expenditure contributes in raising the significant growth of the shwachman-diamond syndrome market. Asia-Pacific is expected to grow in the over coming years due to increased new research and developments on shwachman-diamond syndrome (SDS) and exocrine pancreatic insufficiency which is related to shwachman-diamond syndrome market.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

The shwachman-diamond syndrome market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to shwachman-diamond syndrome market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the shwachman-diamond syndrome market in the growth period.

Competitive Landscape and Global Shwachman-Diamond Syndrome Market Share Analysis

The shwachman-diamond syndrome market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global shwachman-diamond syndrome market.

Os principais players abordados no relatório de mercado global da síndrome do diamante de shwachman são a AbbVie, Inc, Allergan plc., Nordmark Arzneimittel GmbH & Co. KG, Digestive Care, Inc., Janssen Pharmaceuticals, Inc., Cilian AG, Anthera Pharmaceuticals, Inc. e AzurRx Biopharma, Inc. entre outros players nacionais e globais. Os dados de quota de mercado estão disponíveis para a global, América do Norte, Europa, Ásia-Pacífico (APAC), Médio Oriente e África (MEA) e América do Sul separadamente. Os analistas DBMR compreendem os pontos fortes competitivos e fornecem análises competitivas para cada concorrente em separado.

SKU-60085